Research shows that women and underrepresented groups only apply to jobs only if they think they meet 100% of the qualifications on a job description. IMO Health is committed to considering all candidates even if you don’t think you meet 100% of the qualifications listed. We look forward to receiving your application!
IMO Health is a clinical data intelligence business improving how data is used across the healthcare landscape. Combining rich, highly nuanced medical terminology, extensive domain knowledge, and artificial intelligence (AI), we expertly structure and operationalize clinical data to generate sharper insights and inform more intelligent decision-making.
This position follows a hybrid work model, with three days onsite (Tuesday through Thursday) at our Rosemont HQ, Chicago, or Houston office.
We are seeking a motivated and detail-oriented Commercialization Intern to join our team in Rosemont, IL. This internship offers hands-on experience in product commercialization, go-to-market strategies, and cross-functional collaboration. As a member of the commercialization team, you will support key initiatives that bridge product development and market launch efforts, helping to drive IMO Health’s growth.
At IMO Health, we celebrate diversity and are committed to creating an inclusive environment for all employees. IMO Health is proud to be an equal opportunity workplace and is an affirmative action employer.
IMO Health also provides visa sponsorship opportunities. Please don't hesitate to apply if you meet all the qualifications for this position and require visa sponsorship.
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
IMO Health's leadership team is committed to fostering a culture that supports diversity, inclusion, and authenticity. Our hybrid workplace provides the flexibility employees need, and this deliberate, agile approach is key to our success. But a c...
41 jobsSubscribe to Rise newsletter